Original Article
Mortality and morbidity in patients with X-linked agammaglobulinaemia
H. Abolhassania,b, A. Hirbod-Mobarakeha, S. Shahinpoura, M. Panahia, P. Mohammadinejada, B. Mirminachia, M.S. Shakaria, B. Samavata, A. Aghamohammadia,
Corresponding author
a Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
b Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at the Karolinska University Hospital Huddinge, Stockholm, Sweden
Read
5363
Timeswas read the article
813
Total PDF
4550
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 76 | 4 | 80 |
| 2025 11 | 144 | 16 | 160 |
| 2025 10 | 106 | 16 | 122 |
| 2025 9 | 94 | 20 | 114 |
| 2025 8 | 93 | 14 | 107 |
| 2025 7 | 114 | 4 | 118 |
| 2025 6 | 121 | 8 | 129 |
| 2025 5 | 112 | 5 | 117 |
| 2025 4 | 137 | 1 | 138 |
| 2025 3 | 121 | 4 | 125 |
| 2025 2 | 82 | 5 | 87 |
| 2025 1 | 62 | 3 | 65 |
| 2024 12 | 89 | 6 | 95 |
| 2024 11 | 72 | 5 | 77 |
| 2024 10 | 49 | 4 | 53 |
| 2024 9 | 90 | 2 | 92 |
| 2024 8 | 64 | 4 | 68 |
| 2024 7 | 82 | 6 | 88 |
| 2024 6 | 74 | 7 | 81 |
| 2024 5 | 105 | 4 | 109 |
| 2024 4 | 100 | 11 | 111 |
| 2024 3 | 93 | 4 | 97 |
| 2024 2 | 69 | 5 | 74 |
| 2024 1 | 88 | 6 | 94 |
| 2023 12 | 65 | 5 | 70 |
| 2023 11 | 111 | 9 | 120 |
| 2023 10 | 91 | 10 | 101 |
| 2023 9 | 45 | 3 | 48 |
| 2023 8 | 54 | 9 | 63 |
| 2023 7 | 63 | 6 | 69 |
| 2023 6 | 82 | 4 | 86 |
| 2023 5 | 98 | 5 | 103 |
| 2023 4 | 75 | 14 | 89 |
| 2023 3 | 94 | 10 | 104 |
| 2023 2 | 63 | 7 | 70 |
| 2023 1 | 58 | 12 | 70 |
| 2022 12 | 71 | 4 | 75 |
| 2022 11 | 48 | 17 | 65 |
| 2022 10 | 41 | 12 | 53 |
| 2022 9 | 38 | 14 | 52 |
| 2022 8 | 36 | 9 | 45 |
| 2022 7 | 19 | 11 | 30 |
| 2022 6 | 21 | 7 | 28 |
| 2022 5 | 23 | 4 | 27 |
| 2022 4 | 39 | 14 | 53 |
| 2022 3 | 48 | 9 | 57 |
| 2022 2 | 39 | 10 | 49 |
| 2022 1 | 49 | 14 | 63 |
| 2021 12 | 17 | 18 | 35 |
| 2021 11 | 37 | 14 | 51 |
| 2021 10 | 28 | 12 | 40 |
| 2021 9 | 23 | 16 | 39 |
| 2021 8 | 34 | 9 | 43 |
| 2021 7 | 14 | 11 | 25 |
| 2021 6 | 19 | 8 | 27 |
| 2021 5 | 18 | 14 | 32 |
| 2021 4 | 75 | 12 | 87 |
| 2021 3 | 40 | 12 | 52 |
| 2021 2 | 21 | 11 | 32 |
| 2021 1 | 40 | 3 | 43 |
| 2020 12 | 5 | 0 | 5 |
| 2020 11 | 0 | 1 | 1 |
| 2020 10 | 1 | 0 | 1 |
| 2020 9 | 0 | 1 | 1 |
| 2020 8 | 0 | 1 | 1 |
| 2020 7 | 0 | 2 | 2 |
| 2020 5 | 0 | 1 | 1 |
| 2020 1 | 0 | 2 | 2 |
| 2019 12 | 0 | 1 | 1 |
| 2019 11 | 0 | 1 | 1 |
| 2019 10 | 0 | 2 | 2 |
| 2019 8 | 0 | 1 | 1 |
| 2019 7 | 0 | 2 | 2 |
| 2019 6 | 0 | 1 | 1 |
| 2019 5 | 0 | 20 | 20 |
| 2018 3 | 3 | 0 | 3 |
| 2018 2 | 16 | 5 | 21 |
| 2018 1 | 16 | 3 | 19 |
| 2017 12 | 27 | 5 | 32 |
| 2017 11 | 17 | 4 | 21 |
| 2017 10 | 15 | 5 | 20 |
| 2017 9 | 16 | 4 | 20 |
| 2017 8 | 32 | 4 | 36 |
| 2017 7 | 16 | 3 | 19 |
| 2017 6 | 15 | 16 | 31 |
| 2017 5 | 24 | 17 | 41 |
| 2017 4 | 29 | 15 | 44 |
| 2017 3 | 29 | 18 | 47 |
| 2017 2 | 47 | 7 | 54 |
| 2017 1 | 20 | 6 | 26 |
| 2016 12 | 27 | 9 | 36 |
| 2016 11 | 21 | 6 | 27 |
| 2016 10 | 28 | 7 | 35 |
| 2016 9 | 24 | 11 | 35 |
| 2016 8 | 28 | 5 | 33 |
| 2016 7 | 10 | 4 | 14 |
| 2016 6 | 22 | 7 | 29 |
| 2016 5 | 10 | 9 | 19 |
| 2016 4 | 15 | 11 | 26 |
| 2016 3 | 20 | 15 | 35 |
| 2016 2 | 18 | 17 | 35 |
| 2016 1 | 17 | 15 | 32 |
| 2015 10 | 0 | 1 | 1 |
| 2015 5 | 0 | 4 | 4 |
| 2015 4 | 3 | 9 | 12 |
| 2015 3 | 0 | 7 | 7 |
| 2015 2 | 5 | 5 | 10 |
Show all
